Patent · US Active

Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}

US9643950B2 · kind B2 · utility

0Cited by

8References

3Claims

0Family size

Assignee

Concert Pharmaceuticals, Inc. · US

Inventors

Joanna Bis · Cary, US
David H. Igo · Morrisville, US

Key dates

Filing date	Oct 21, 2013
Grant date	May 9, 2017
Priority date	—
Expiry date	Oct 21, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention in one embodiment is directed to solid forms of {S-3-(4-Amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}, including an anhydrous crystalline form, two hydrates, and an amorphous form. The invention in one embodiment is directed to methods of preparation of the solid forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.